Pregnancy And Neonatal Outcomes Of hMG Stimulation With Or Without Letrozole In Endometrial Preparation For Frozen-Thawed Embryo Transfer In Ovulatory Women: A Large Retrospective Cohort Study
Pregnancy And Neonatal Outcomes Of hMG Stimulation With Or Without Letrozole In Endometrial Preparation For Frozen-Thawed Embryo Transfer In Ovulatory Women: A Large Retrospective Cohort Study
复制标题
排卵期女性冻融胚胎移植子宫内膜准备中使用或不使用来曲唑的 hMG 刺激的妊娠和新生儿结局:一项大型回顾性队列研究
DOI:
10.2147/dddt.s212235
复制
发表时间:
2019-01-01
影响因子:
4.8
通讯作者:
Wang, Yun
中科院分区:
文献类型:
--
作者:
Lin, Jiaying;Wang, Ningling;Wang, Yun
Objective: Frozen-thawed embryo transfer enables surplus embryos derived from IVF or IVF-ICSI treatment to be stored and transferred in subsequent cycles into a more "physiologic environment". This study aimed to investigate the clinical effect of letrozole use or hMG stimulation on pregnancy and neonatal outcomes in ovulatory patients undergoing FET.Methods: This study includes a total of 5901 FET cycles with letrozole use (n = 1569), HMG (n = 1827) or letrozole + HMG (n = 2505). In the letrozole group, 2.5 mg of letrozole was administered on menstrual cycle day 3 to 5 for 3 days for patients, and then follicle growth was monitored beginning on day 10. If the follicular diameter was >= 14 mm on the 10th day, no other ovarian stimulation drugs were needed. If the follicular diameter was